InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Kelly, Scott. Director active across 2 companies, notably Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.). In total, 14 disclosures have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €257k. Activity tracked since 29 May 2026. The latest transaction was filed on 28 August 2026 (11 - Acquisition or disposition carried out privately). Regulator: SEDI. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
Scott Kelly has filed 13 forms in total. Across the 13 most recent sampled filings, purchases amount to EUR 109330, sales to EUR 0, and the period runs from 2026-06-03 to 2026-07-25. He is a director of issuer at Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.) and a senior officer of issuer at First Canadian Graphite Inc.